Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam with low-dose propofol for sedation in hysteroscopic surgery
ChiCTR2100055034Phase 4Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam, propofol and alfentanil in endometriosis (3 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Pulse oximetry. Started Dec 2021; status: recruiting.
02
Drugs
remimazolampropofolalfentanil
03
Conditions
endometriosis
Beyond the preview
Go deeper on ChiCTR2100055034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100055034.